From: Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
 | Rheumatoid arthritis patients | Healthy controls |
---|---|---|
Number | 48 | 33 |
Age | 56 ± 13 | 43 ± 13 |
% female | 75 | 43 |
Disease duration (years) | 12 ± 10 | – |
Cyclic citrullinated peptide IgG (units) | 232 ± 397 | – |
Rheumatoid factor (IU/ml) | 133 ± 236 | – |
C-reactive protein (mg/dl) | 1 ± 1.75 | – |
Disease activity score | 3.1 ± 1.5 | – |
DMARDs (%) | 92% | – |
TNFα inhibitors (%) | 54% | – |
Prednisone (%) | 23% | – |